Safety, effectiveness and sustainability of a laboratory intervention to de-adopt culture of midstream urine samples among hospitalized patients.
Mohammad MozafarihashjinJerome A LeisLorraine Maze Dit MieusementLiz McCreightSusan PoutanenAnanya ShrivastavaJannice SoChristine SoongLiz van HorneLouis WongAllison J McGeerPublished in: Infection control and hospital epidemiology (2020)
De-adopting the processing of MSU cultures from medical and surgical inpatient units is safe and sustainable, and it reduces antibiotic prescriptions for ASB at a cost of prolonged urinary symptoms in a small proportion of patients.